SCHEMBL7235879

SCHEMBL7235879

COC(=O)C1=C(C(=O)Nc2nc(-c3ccc4ccccc4c3)cs2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.64
▸ NPC1 O15118 2/20 0.64
▸ MEN1 O00255 8/20 0.58
▸ KMT2A Q03164 8/20 0.58
▸ MAPT P10636 4/20 0.58
▸ KDM4E B2RXH2 2/20 0.58
▸ GSTO1 P78417 1/20 0.57
▸ AR P10275 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.52
▸ MAOA P21397 1/20 0.51
▸ MAOB P27338 1/20 0.51
▸ ADORA3 P0DMS8 1/20 0.51
▸ CSNK2A1 P68400 2/20 0.51
▸ SLC6A2 P23975 2/20 0.50
▸ SLC6A3 Q01959 2/20 0.50
▸ ALDH1A1 P00352 4/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ POLB P06746 2/20 0.49
▸ HTT P42858 2/20 0.49
▸ HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7240624 0.88 RAB9A (0.71) RAB9ANPC1MEN1KMT2AMAPT
SCHEMBL7235764 0.84 RAB9A (0.77) RAB9ANPC1MEN1KMT2AMAPT
SCHEMBL7240497 0.83 RAB9A (0.69) RAB9ANPC1MEN1KMT2AMAPT
SCHEMBL7229929 0.83 RAB9A (0.69) RAB9ANPC1MEN1KMT2AMAPT
SCHEMBL7229223 0.78 RAB9A (0.64) RAB9ANPC1MEN1KMT2AMAPT
SCHEMBL5732213 0.77 RAB9A (0.70) RAB9ANPC1MEN1KMT2AMAPT
SCHEMBL7253225 0.77 RAB9A (0.70) RAB9ANPC1MEN1KMT2AMAPT
SCHEMBL20512983 0.77 KDM4E (0.69) RAB9ANPC1MEN1KMT2AMAPT
SCHEMBL30581066 0.77 RAB9A (0.78) RAB9ANPC1MEN1KMT2AMAPT
SCHEMBL7239062 0.76 RAB9A (1.00) RAB9ANPC1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030055263-A1 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055263-A1 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production TERT, POT1, REV1 RAB9A 3964/4885NPC1 2716/4885MEN1 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback